论文部分内容阅读
目的观察硬膜外分娩镇痛中地佐辛复合罗哌卡因的可行性与安全性。方法 200例阴道分娩产妇,按照自愿原则分为观察组和对照组,各100例。观察组产妇给予地佐辛复合罗哌卡因硬膜外镇痛(PCEA),采用硬膜外无痛分娩技术。对照组产妇不给予镇痛,采用常规阴道分娩。对比两组产妇分娩情况。结果观察组产妇疼痛程度轻于对照组(P<0.05)。观察组产妇总产程明显短于对照组(P<0.05);观察组剖宫产率为6.0%,明显低于对照组19.0%(P<0.05);两组产妇产后出血率和新生儿窒息率比较差异无统计学意义(P>0.05)。结论地佐辛罗哌卡因PCEA分娩镇痛效果可靠,不良反应少。
Objective To observe the feasibility and safety of zooxacin combined with ropivacaine in epidural analgesia. Methods 200 cases of vaginal delivery of mothers, according to the principle of voluntary divided into observation group and control group, each 100 cases. Observation group maternal administration of dezocine combined ropivacaine epidural analgesia (PCEA), using epidural painless delivery technology. Control group of mothers do not give analgesia, the use of conventional vaginal delivery. Contrast two groups of maternal childbirth. Results The degree of pain in the observation group was lower than that in the control group (P <0.05). The total labor duration in the observation group was significantly shorter than that in the control group (P <0.05). The rate of cesarean section in the observation group was 6.0%, significantly lower than that in the control group (19.0%, P <0.05). The postpartum hemorrhage rate and neonatal asphyxia rate The difference was not statistically significant (P> 0.05). Conclusion The dezocine ropivacaine has a reliable analgesic effect with PCEA and few adverse reactions.